Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 03, 2021

SELL
$282.99 - $369.05 $28,299 - $36,905
-100 Closed
0 $0
Q4 2020

Feb 19, 2021

BUY
$236.26 - $355.63 $23,626 - $35,563
100 New
100 $24,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Wilsey Asset Management Inc Portfolio

Follow Wilsey Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilsey Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wilsey Asset Management Inc with notifications on news.